Skip to content
Pharmacology & Mechanisms

Phase 2 trial

The clinical trial stage that evaluates efficacy, optimal dosing, and side effects in 100–300 patients with the target condition. Phase 2 results determine whether to proceed to large Phase 3 trials.

Frequently Asked Questions

What is Phase 2 trial?
The clinical trial stage that evaluates efficacy, optimal dosing, and side effects in 100–300 patients with the target condition. Phase 2 results determine whether to proceed to large Phase 3 trials.
Why is Phase 2 trial important in peptide research?
Phase 2 trial is a key pharmacological concept that determines how peptides interact with the body. Understanding this term helps practitioners optimize dosing protocols, predict therapeutic outcomes, and minimize side effects.

Related Terms

Phase 1 trial

The first stage of human clinical testing, focused on safety, tolerability, pharmacokinetics, and dose-ranging in 20–100 healthy volunteers. Determines the maximum tolerated dose.

Phase 3 trial

Large-scale randomized controlled trials (1,000–3,000+ patients) comparing the investigational peptide to placebo or standard of care. Positive Phase 3 results are required for FDA approval.

Clinical trial phases

The staged process of testing a new drug in humans: Phase 1 (safety), Phase 2 (efficacy), Phase 3 (large-scale confirmation), and Phase 4 (post-marketing surveillance). Each phase has specific objectives and requirements.

← Back to full glossary